Tonix Pharma (TNXP) has released an update to notify the public and investors about the submission of matters to a vote of security holders.
At the Special Meeting, Company shareholders, representing 67.58% of outstanding common stock as of the record date, approved two key proposals. The first proposal was to amend the Company’s Articles of Incorporation to increase authorized shares of common stock from 160 million to 1 billion. The second proposal allowed for the adjournment of the meeting to solicit more proxies in the event there weren’t enough votes to approve the first proposal. Both proposals were passed with a majority of votes in favor.
For further insights into TNXP corporate activity, check out TipRanks’ Insiders Trading Activity page.
